MISSION STATEMENT

The Respiratory Physiology Laboratory of the University of Cyprus Medical School aims to develop and provide high quality diagnostic and clinical services to respiratory patients from Cyprus and abroad. Furthermore, the Respiratory Physiology Laboratory is involved in the educational activities of the Medical school and carries out innovative research in the fields of diagnostics, prophylaxis and treatment of respiratory diseases as well as in environmental and public health.

Moreover, the Respiratory Physiology Laboratory, in collaboration with the Cyprus Institute of Neurology and Genetics and the Archbishop Makarios III Hospital, hosts the national Primary Ciliary Dyskinesia Service (PCD Service) and offers state of the art diagnostic and clinical services to PCD patients.

The Respiratory Physiology Laboratory is a RespiHubfounding member laboratory.

The Respiratory Physiology Laboratory is a European Reference Network for rare respiratory diseases member laboratory since 2022.

BASIC ACTIVITIES

Provide training for the students of the University of Cyprus Medical School.

Development of innovative research in the fields of diagnostics, prophylaxis and treatment of respiratory diseases.

Explore novel approaches and inform policy making in the fields of environmental and public health.

Participation in international studies for respiratory diseases and for environmental and public health through the collaboration with other academic and research institutes in Cyprus and abroad.

The organization of public awareness events regarding the effect of environmental or lifestyle factors on public health and more specifically on respiratory diseases.

PRIMARY CILIARY DYSKINESIA

Primary Ciliary Dyskinesia (PCD) is a rare, genetically heterogeneous disorder which results from the dysfunction of small hair-like organelles, called motile cilia. Motile cilia project from the apical side of epithelial cells that line up the upper and lower airways (respiratory cilia) and can be found in a variety of other tissues. PCD patients usually suffer from recurrent respiratory infections which lead to chronic destructive airway disease characterized by progressive loss of lung function and structural damage to the airways (bronchiectasis).

EVERYTHING YOU NEED TO KNOW ABOUT PCD

Cystic Fibrosis

Cystic Fibrosis (CF) is a hereditary multi-organ disease caused by pathogenic alterations in the gene of the cystic fibrosis transmembrane conductance regulator (CFTR), a protein that regulates chloride transport in the cell membrane. The disease affects mostly the lungs, causing sticky mucus secretions and frequent infections, but also the liver, the pancreas, body growth, etc. In Cyprus, due to high temperatures, about 34% of patients present with severe dehydration and electrolyte disorders as the first symptom of the disease.

CF care in Cyprus has been implemented since 1997, after the establishment of a tertiary Pediatric Pulmonology Clinic in the ‘‘Archbishop Makarios III’’ Hospital in Nicosia. The prevalence of CF at birth in Cyprus is around 1 in 8000 live births.  

EVERYTHING YOU NEED TO KNOW ABOUT CF

Latest News

GET IN TOUCH

1 + 15 =

AFFILIATED INSTITUTIONS / COLLABORATORS

RPL Medical Research Team